| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |